Insider plans Rule 144 sale of common stock

A holder of KURA common stock filed a notice of intent to sell shares under Rule 144.

Rhea-AI Filing Summary

A holder of KURA common stock filed a notice of intent to sell shares under Rule 144. The planned sale covers 6,414 shares of common stock with an aggregate market value of $54,326.58, to be executed through Morgan Stanley Smith Barney on 01/27/2026 on NASDAQ. The shares come from restricted stock units acquired from the issuer on the same date in two grants of 4,842 and 1,572 shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the KURA Form 144 filing disclose about planned share sales?

The Form 144 discloses a planned sale of 6,414 shares of KURA common stock under Rule 144. These shares have an aggregate market value of $54,326.58 and are expected to be sold on 01/27/2026 through Morgan Stanley Smith Barney on NASDAQ.

How were the KURA shares in the Form 144 acquired?

The KURA shares were acquired as restricted stock units (RSUs) from the issuer on 01/27/2026. The filing lists two RSU transactions, one for 4,842 shares and another for 1,572 shares, both with payment dated the same day and marked as non-cash (N/A).

What is the market value and size of the KURA Rule 144 sale?

The planned Rule 144 sale covers 6,414 common shares of KURA with an aggregate market value of $54,326.58. The issuer has 88,309,441 shares of common stock outstanding, which the filing provides as context for the relative size of this contemplated transaction.

When is the KURA Rule 144 sale expected to occur and on which exchange?

The filing lists an approximate sale date of 01/27/2026 for the KURA shares. The securities are common stock to be sold on the NASDAQ exchange, with Morgan Stanley Smith Barney Executive Financial Services named as the broker handling the planned transaction.

What representation does the seller make in the KURA Form 144 notice?

The seller represents that they do not know any material adverse information about KURA’s current or prospective operations that has not been publicly disclosed. This representation also applies as of any date a written trading plan or trading instructions under Rule 10b5-1 were adopted.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/27/2026 - 09:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001934232
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	KURA ONCOLOGY, INC.
SEC File Number	001-37620
Address of Issuer	4930 Directors Place, Suite 500 San Diego CALIFORNIA 92121
Phone	(858)-500-8800
Name of Person for Whose Account the Securities are To Be Sold	POWL BRIAN T
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6414	54326.58	88309441	01/27/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/27/2026	RSU	Issuer			4842	01/27/2026	N/A
Common Stock	01/27/2026	RSU	Issuer			1572	01/27/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Teresa Bair, Attorney-in-fact for Brian Powl
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)